1.
Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids. Reumatismo [Internet]. 2014 Mar. 17 [cited 2025 Jul. 2];65(6):286-91. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2013.691